smart inhaler

By Jonah Comstock December 1, 2015
GSK's Ellipta inhaler GlaxoSmithKline and Madison, Wisconsin-based Propeller Health announced a partnership today in which Propeller will develop and manufacture a custom sensor for GSK's Ellipta inhaler for COPD patients. Like the other inhaler sensors Propeller has developed, the device will record when and where the patient uses the inhaler and wirelessly transmit that information to GSK ...
By Jonah Comstock September 30, 2015
Adherium, the Australian connected inhaler company that partnered with AstraZeneca earlier this summer, has released data from three small studies of the company's Smartinhaler system. Data from the studies, all of which involved children and adolescents, indicate a 144 percent increase in adherence for patients using the connected devices, a 14.9 percent increase in lung function and a 37...
By Jonah Comstock September 27, 2015
Teva Pharmaceuticals will acquire Cambridge, Massachusetts-based Gecko Health Innovations (previously known as GeckoCap), a smart inhaler company. The terms of the deal were not disclosed. Gecko's main product is CareTRx a platform for chronic respiratory disease management that combines a sensor device that connects to most inhalers, a data analytics platform, an accessible user interface, and...
By Jonah Comstock August 19, 2015
Adherium Limited, a New Zealand company working on a smart inhaler, has raised $25.6 million ($35 million AU) in an initial public offering on the Australian Securities Exchange, including a $3 million investment from its partner pharma company AstraZeneca, which just last month announced a longterm commercialization agreement with the company. Adherium makes a line of medical devices that...
By Jonah Comstock October 8, 2014
CoheroHealth, a New York City-based startup working on medication adherence tracking for asthma inhalers, is launching a small pilot with Mount Sinai Medical Center. The company will test its platform, which includes an inhaler sensor, a mobile app, and a connected spirometer, on 50 pediatric asthma patients. "There are 50 million patients with respiratory disease and it costs $80 billion per...
By Brian Dolan September 4, 2014
Madison, Wisconsin-based Propeller Health, formerly known as Asthmapolis, has raised $14.5 million in a round of funding led by Safeguard Scientifics with participation from return backer The Social+Capital Partnership. Propeller has also hired Practice Fusion's Chris Hogg as its first COO, and he'll head up the company's new San Francisco office. The smart inhaler company's devices and companion...
By Jonah Comstock May 6, 2014
Propeller Health, formerly Asthmapolis, has received FDA clearance for a platform that includes a new smart inhaler and is geared for patients with either asthma or COPD. "Our goal is to minimize or eliminate exacerbations – that drives everything we do. Key to that, particularly as we move deeper into COPD, is optimizing both the patient and provider experience on Propeller," David Van Sickle,...
By Jonah Comstock April 17, 2014
The Inspiromatic inhaler. Biopharmaceutical company Opko Health has acquired Israeli smart inhaler company Inspiro Medical for a sum in "the low eight figures", according to Opko's Director of Strategic Investment Les Funtleyder. The company will be using Inspiro's Inspiromatic technology to develop an app-connected inhaler that will be bundled with a forthcoming new drug for asthma, COPD, and...